Contineum Therapeutics, Inc. (NASDAQ:CTNM) Receives Average Rating of “Buy” from Analysts
Shares of Contineum Therapeutics, Inc. (NASDAQ:CTNM – Get Free Report) have been given an average recommendation of “Buy” by the six analysts that are currently covering the firm, Marketbeat reports. Five investment analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average 1 […]
Shares of Contineum Therapeutics, Inc. (NASDAQ:CTNM – Get Free Report) have been given an average recommendation of “Buy” by the six analysts that are currently covering the firm, Marketbeat reports. Five investment analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average 1 […]
